Pharma's Almanac | Excipients

40 Articles Available

0 2

Viscosity Reduction

Viscosity Reduction with An Excipient Platform and Feasibility Testing Service

PAO-08-23-CL-03

Alternative Excipient

Preparing Today for a Potential Ban on Titanium Dioxide in Pharmaceutical Drug Products

PAO-08-23-CL-01

Modified-Release Drug Formulations

Simplifying Modified-Release Drug Formulations with High-Quality Multiparticulate Cores

PAO-05-23-CL-06

Distribution

Redefining Innovation and Growth in Pharmaceutical Distribution

PAO-06-23-CL-03

3D Printing

Advancing Extrusion-Based 3D Printing for Drug Production

PAO-11-022-CL-14

Sweeteners

High-Intensity Sweeteners for Taste Optimization

PAO-11-022-CL-12

Taste Masking Formulations

Formulating Flexibility with ActiMask® Taste Masking

PAO-10-022-CL-05

Lipid Excipients

Regulatory Considerations for Lipid Excipients

PAO-07-022-CL-04

Excipient Quality Assurance

Assuring Excipient Quality for Parenteral Products

Advanced Excipients

How the Developability Classification System and Advanced Excipients Enable the Formulation of Poorly Soluble APIs

PAO-04-022-CL-07

Excipients

Enabling Stable, High-Viscosity Injectable Drug Products with New Excipient Combinations

PAO-01-22-CL-02

Formulation

Incorporating Patient Voices from the Start of Drug Development

PAO-01-22-R250-10

Formulation

Accelerating Biologics Development with High-Quality Protein Stabilization Excipients

PAO-11-21-CL-12

Tablet Coating

An Easy-to-Use Tablet Coating Polymer to Increase Coating Process Efficiency and Flexibility

PAO-09-21-CL-06

Orally Disintegrating Tablets

A Revolutionary Excipient Platform for Super-Fast Disintegrating ODTs

PAO-07-21-CL-03

Hot Melt Extrusion

Solving Solubility Challenges with a Polyvinyl Alcohol Excipient and Hot Melt Extrusion

PAP-Q4-20-CL-016

The Future of Healthcare

How Does SPI Pharma Envision the Future of the Pharma/Biopharma Industry?

PAP-Q4-20-RT2-009

Orally Disintegrating Tablets

Qualifying ODT Excipient Systems Beyond Disintegration Performance

PAO-10-20-CL-03

Wet Granulation

The Application of Mannitol In Wet Granulation

PAO-10-20-CL-01

The Future of Healthcare

How Is SPI Pharma Evolving its Business Model to Meet the Future of Healthcare?

PAP-Q3-20-RT2-004

Excipients

New Mannitol Formulations Are a Gem of a Collection

PAP-Q1-20-CL-004

Collaboration

Context Therapeutics Signs Strategic Research Collaborations for Apristor® (onapristone extended release) With Key Academic Leaders in the Progesterone Receptor (PR) and Breast Cancer Fields

PR-M08-18-NI-086

Manufacturing

Colorcon Up and Running in Puerto Rico

PAO-M03-18-NI-011

Excipients

Celanese on the Road to BIO: Excipients In Biologics

PTV-M06-17-CL-010

0 2

Excipients

40 Articles Available

Can't find what you're looking for? Try our advanced search.

Viscosity Reduction

Viscosity Reduction with An Excipient Platform and Feasibility Testing Service

Alternative Excipient

Preparing Today for a Potential Ban on Titanium Dioxide in Pharmaceutical Drug Products

Modified-Release Drug Formulations

Simplifying Modified-Release Drug Formulations with High-Quality Multiparticulate Cores

Distribution

Redefining Innovation and Growth in Pharmaceutical Distribution

3D Printing

Advancing Extrusion-Based 3D Printing for Drug Production

Sweeteners

High-Intensity Sweeteners for Taste Optimization

Taste Masking Formulations

Formulating Flexibility with ActiMask® Taste Masking

Lipid Excipients

Regulatory Considerations for Lipid Excipients

Excipient Quality Assurance

Assuring Excipient Quality for Parenteral Products

Advanced Excipients

How the Developability Classification System and Advanced Excipients Enable the Formulation of Poorly Soluble APIs

Excipients

Enabling Stable, High-Viscosity Injectable Drug Products with New Excipient Combinations

Formulation

Incorporating Patient Voices from the Start of Drug Development

Formulation

Accelerating Biologics Development with High-Quality Protein Stabilization Excipients

Tablet Coating

An Easy-to-Use Tablet Coating Polymer to Increase Coating Process Efficiency and Flexibility

Orally Disintegrating Tablets

A Revolutionary Excipient Platform for Super-Fast Disintegrating ODTs

Hot Melt Extrusion

Solving Solubility Challenges with a Polyvinyl Alcohol Excipient and Hot Melt Extrusion

The Future of Healthcare

How Does SPI Pharma Envision the Future of the Pharma/Biopharma Industry?

Orally Disintegrating Tablets

Qualifying ODT Excipient Systems Beyond Disintegration Performance

Wet Granulation

The Application of Mannitol In Wet Granulation

The Future of Healthcare

How Is SPI Pharma Evolving its Business Model to Meet the Future of Healthcare?

Excipients

New Mannitol Formulations Are a Gem of a Collection

Collaboration

Context Therapeutics Signs Strategic Research Collaborations for Apristor® (onapristone extended release) With Key Academic Leaders in the Progesterone Receptor (PR) and Breast Cancer Fields

Manufacturing

Colorcon Up and Running in Puerto Rico

Excipients

Celanese on the Road to BIO: Excipients In Biologics